Bulevirtide Clinical Trials
7 recruitingDrug
Phase 32Phase 21
Showing 1–7 of 7 trials
Recruiting
Phase 2Phase 3
Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving Bulevirtide
Chronic Hepatitis D
Mirum Pharmaceuticals, Inc.120 enrolled22 locationsNCT07454837
Recruiting
Phase 3
A Study to Evaluate Tobevibart+Elebsiran in Participants With Chronic HDV Infection Not Virologically Suppressed With Bulevirtide
Viral Hepatitis
Vir Biotechnology, Inc.150 enrolled36 locationsNCT07128550
Recruiting
Oral-Periodontal Evaluation and Assessment of Oral Fluid Biomarkers in Patients With Hepatitis B+D
Research Center of Periodontal-Systemic Interactions25 enrolled2 locationsNCT07491848
Recruiting
Immunological and Virological Characterization of Patients With Chronic HBV-HDV Infection: Outcomes and Response to Bulevirtide Treatment
Hepatitis D
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico192 enrolled1 locationNCT06504485
Recruiting
Effectiveness and Safety of Bulevirtide (BLV) Therapy in Patients With Chronic Hepatitis Delta (CHD) in Italy (D-SHIELD)
Hepatitis D
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico100 enrolled1 locationNCT06122285
Recruiting
Effectiveness and Clinical Outcomes of Long-term Bulevirtide Monotherapy in Patients With HDV-related Compensated Cirrhosis
Hepatitis D
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico266 enrolled1 locationNCT06397859
Recruiting
Study to Evaluate Efficacy, Safety and Biomarkers of Bulevirtide Treatment in Chronic Hepatitis D Patients
Chronic Hepatitis D
Karolinska University Hospital400 enrolled1 locationNCT06051045